US – Federal: The US Office of Special Counsel (OSC) has written to the president and Congress advising them that the US Food and Drug Administration (FDA)’s Center for Tobacco Products (CTP) had “relaxed its standards of review for certain tobacco products”. A CTP toxicologist-turned-whistleblower disclosed that a 2019 memo to CTP scientists on how to evaluate potentially harmful ingredients in substantial equivalence applications directed » Continue Reading....
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the TobaccoIntelligence team.